Synovial Sarcoma (SS) Epidemiology Forecast to 2030: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Synovial Sarcoma (SS) – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.
This ‘Synovial Sarcoma (SyS) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of and historical and forecasted epidemiology of synovial sarcoma in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Synovial Sarcoma Epidemiology
The SyS epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
Key Findings
The total incident cases of synovial sarcoma patients are increasing in the 7MM during the study period, i.e., 2018-2030.
The disease epidemiology covered in the report provides historical as well as forecasted synovial sarcoma symptoms epidemiology segmented as the incidence of synovial sarcoma, gender-specific cases of synovial sarcoma, age-specific cases of synovial sarcoma, location-specific cases of synovial sarcoma, and stage-specific cases of synovial sarcoma.
The report includes the incident scenario of synovial sarcoma symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.
Country-wise Synovial Sarcoma Epidemiology
The epidemiology segment also provides the synovial sarcoma epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The total diagnosed incident cases of synovial sarcoma associated in 7MM countries were 1,610 in 2020.
- As per the estimates, the United States has the largest incident population of synovial sarcoma.
- Among the EU5 countries, Germany had the highest incident cases of synovial sarcoma, followed by France. On the other hand, Spain had the lowest prevalent cases with 116 cases in 2020.
Key Topics Covered:
1 Key Insights
2 Report Introduction
3 Synovial Sarcoma Epidemiology Overview at a Glance
3.1 Patient Share (%) Distribution of Synovial Sarcoma in 2018
3.2 Patient Share (%) Distribution of Synovial Sarcoma in 2030
4 Executive Summary of Synovial Sarcoma
5 Disease Background and Overview
5.1 Introduction
5.2 Soft tissue sarcoma
5.3 Signs and Symptoms
5.4 Genetics of Synovial Sarcoma
5.5 Clinical and pathologic features
5.6 Histopathologic and Immunohistochemical findings
5.7 Differential Diagnosis
5.8 Diagnosis
5.9 Treatment
5.9.1 Treatment Guidelines
5.9.2 UK Guidelines for Management of Soft-tissue Sarcomas
6 Epidemiology and Patient Population
6.1 Key Findings
6.2 7MM Total Diagnosed Incident Population of Synovial Sarcoma
6.3 Epidemiology of Synovial Sarcoma
6.4 The United States
6.4.1 Incidence of Synovial Sarcoma in the United States
6.4.2 Gender-specific cases of Synovial Sarcoma in the United States
6.4.3 Age-specific cases of Synovial Sarcoma in the United States
6.4.4 Location-specific cases of Synovial Sarcoma in the United States
6.4.5 Stage-specific cases of Synovial Sarcoma in the United States
6.5 EU5
6.5.1 Germany
6.5.2 France
6.5.3 Italy
6.5.4 Spain
6.5.5 United Kingdom
6.6 Japan
7 KOL Views
8 Market Drivers
9 Market Barriers
10 SWOT Analysis
11 Unmet Needs
12 Market Access
13 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/jdnhmp
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
